Alpha Registry
Claim a profile

Person profile

Public information reviewed

Catalina Valencia

Role

President and Director at AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM)

Board role

Director · AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM)

AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM)

Director · Current mandate

Executive
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
2 reviewed
Profile ownership
Not yet claimed
Last reviewed
May 15, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
21 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Executive appointments

President and Director

AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM)

Current

Source effective: 2024-01-30 · Observed: 2026-08-02T06:53:01.391+00:00

confirmedView source

Board appointments

Director

AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM)

Current

Independence: Not stated

Source effective: 2024-01-30 · Observed: 2026-08-02T06:53:01.391+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

AXIM BIOTECHNOLOGIES, INC.

A linked Registry profile is not available in this record.

Director at AXIM BIOTECHNOLOGIES, INC.

Start not stated → End not stated

current · source reported

Observed: 2026-09-10

AXIM BIOTECHNOLOGI…AXIM BIOTECHNOLOGIES, INC.AXIM BIOTECHNOLOGI…AXIM BIOTECHNOLOGIES, INC.Catalina Valencia

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • AXIM BIOTECHNOLOGIES, INC.

    Director

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingAXIM 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 2 · Sec Form OwnershipPublic profile sourceSupports Director at AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM), President and Director at AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM), Board membership.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:catalina-valencia
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board membership · Source reportedServes on the board of AXIM BIOTECHNOLOGIES, INC.Supported by 2 public records1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 15, 2026
Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at AXIM BIOTECHNOLOGIES, INC.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: CEO Sapphire Biotechnologies1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · Source reportedTechnology background reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources2 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  2. https://www.sec.gov/Archives/edgar/data/1514946/000109690624002004/form4.xml

    Sec Form Ownership · Tier not stated · Reviewed Aug 2, 2026

    Supports: Director at AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM) · President and Director at AXIM BIOTECHNOLOGIES, INC. (OTC: AXIM) · Board membership